Modification of Certain Terminology in Title 21
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register May 6, 2026. Document 2026-08826. Updated Nov. 11, 2026.
- What it does
The Food and Drug Administration (FDA, the Agency, or we) is issuing a proposed rule to modify certain terminology in Title 21 of the Code of Federal Regulations (CFR) to comply with Executive Order (E.O.) 14168, "Defending Women From Gender Ideology Extremism and Restoring Biological Truth to the Federal Government," issued on January 20, 2025. Specifically, this proposed rule, if finalized, will remove the term "gender" wherever it appears and either replace it with the term "sex," or delete reference to gender, as applicable, along with other editorial changes to improve readability.
The Food and Drug Administration's summary, as published in the Federal Register.
- What it would change
16 parts of Title 21 of the Code of Federal Regulations:
21 CFR 10, 21 CFR 56, 21 CFR 106, 21 CFR 201, 21 CFR 251, 21 CFR 310, 21 CFR 312, 21 CFR 314, 21 CFR 329, 21 CFR 600, 21 CFR 803, 21 CFR 862, 21 CFR 866, 21 CFR 870, 21 CFR 882, 21 CFR 1114
- Before this
No earlier Federal Register document under regulation identifier 0910-AJ26 since Jan. 1, 2025.
Since then:
- What happens next and when
Submit either electronic or written comments on the proposed rule by July 6, 2026.
The agency's dates, word for word.
The record as published
| Document number | 2026-08826 |
|---|---|
| Action | Proposed rule. |
| Agencies | Health and Human Services Department; Food and Drug Administration |
| Published | May 6, 2026 |
| Comments close | July 6, 2026 |
| Regulation identifier (RIN) | 0910-AJ26 |
| Docket | FDA-2026-N-2886 |
Source: the Federal Register (public domain). The document in the Federal Register